ChemCon

Executive Summary

ChemCon GmbH is a German contract development and manufacturing organization (CDMO) founded in 1995, specializing in GMP-compliant synthesis of active pharmaceutical ingredients (APIs) and fine chemicals. Based in Freiburg, the company serves clients from preclinical development through commercial supply, with expertise in organic, inorganic, and polymer chemistry. Its core offerings include custom synthesis, process development, analytical testing, and regulatory support, particularly for cytotoxic and highly potent compounds. Despite its long history, ChemCon operates in the pre-clinical stage, indicating a focus on early-phase client projects rather than large-scale commercial manufacturing. The company is privately held and has a stable position in the competitive CDMO market, leveraging its specialized capabilities in high-potency APIs to differentiate from larger competitors.

Upcoming Catalysts (preview)

• Q3 2026Expansion of high-potency API manufacturing capacity80% success
• Q4 2026Successful FDA or EMA inspection for GMP compliance75% success
• Q2 2026Strategic partnership with a mid-size biotech for long-term supply agreement70% success